ClinicalTrials.govpublic full text
Pembrolizumab and Enobosarm in Treating Patients With Androgen Receptor Positive Metastatic Triple Negative Breast Cancer
androgen receptor positive, estrogen receptor negative, her2/neu negative, metastatic triple-negative breast carcinoma, progesterone receptor negative, stage iv breast cancer ajcc v6 and v7
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 332737
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.